These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 325178)

  • 41. Anti-candidal activity of essential oils alone and in combination with amphotericin B or fluconazole against multi-drug resistant isolates of Candida albicans.
    Khan MS; Malik A; Ahmad I
    Med Mycol; 2012 Jan; 50(1):33-42. PubMed ID: 21756200
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Incidence of Candida albicans in infant oral materials and feces, and the sensitivity of amphotericin B to them].
    Hashimoto Y; Okuda K; Kametani H; Okumura S; Yonezawa W
    Shikwa Gakuho; 1972 Mar; 72(3):762-6. PubMed ID: 4556676
    [No Abstract]   [Full Text] [Related]  

  • 43. Enhancement effect of N-methyl-N″-dodecylguanidine on the vacuole-targeting fungicidal activity of amphotericin B against the pathogenic fungus Candida albicans.
    Yutani M; Ogita A; Usuki Y; Fujita K; Tanaka T
    J Antibiot (Tokyo); 2011 Jul; 64(7):469-74. PubMed ID: 21522157
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of metabolic energy in the lethal action of basic proteins on Candida albicans.
    Olson VL; Hansing RL; McClary DO
    Can J Microbiol; 1977 Feb; 23(2):166-74. PubMed ID: 189885
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inducible phenotypic multidrug resistance in the fungus Mucor racemosus.
    Leathers TD; Sypherd PS
    Antimicrob Agents Chemother; 1985 Jun; 27(6):892-6. PubMed ID: 4026262
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Population changes induced in Candida albicans by nalidixic acid.
    Sarachek A
    Mycopathologia; 1979 Sep; 68(2):105-20. PubMed ID: 386130
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased amphotericin B methyl ester activity in the presence of antioxidants.
    Beggs WH; Andrews FA; Sarosi GA
    J Antimicrob Chemother; 1980 Mar; 6(2):291-2. PubMed ID: 6991470
    [No Abstract]   [Full Text] [Related]  

  • 48. Peptide transport in Candida albicans.
    Logan DA; Becker JM; Naider F
    J Gen Microbiol; 1979 Sep; 114(1):179-86. PubMed ID: 392049
    [TBL] [Abstract][Full Text] [Related]  

  • 49. N-aminoacyl derivatives of polyene macrolide antibiotics and their esters.
    Wright JJ; Albarella JA; Krepski LR; Loebenberg D
    J Antibiot (Tokyo); 1982 Jul; 35(7):911-4. PubMed ID: 6757233
    [No Abstract]   [Full Text] [Related]  

  • 50. Inhibition of protein synthesis in Saccharomyces cerevisiae by the 12,13-epoxytrichothecenes trichodermol, diacetoxyscirpenol and verrucarin A. Reversibility of the effects.
    Hernández F; Cannon M
    J Antibiot (Tokyo); 1982 Jul; 35(7):875-81. PubMed ID: 6757231
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trichodermin esterase activity and trichodermin resistance in Mucor racemosus.
    Fonzi WA; Sypherd PS
    Antimicrob Agents Chemother; 1986 Apr; 29(4):570-5. PubMed ID: 3707105
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of cyclic AMP on RNA and protein synthesis in Candida albicans.
    Bhattacharya A; Datta A
    Biochem Biophys Res Commun; 1977 Aug; 77(4):1483-44. PubMed ID: 197962
    [No Abstract]   [Full Text] [Related]  

  • 53. It only takes one to do many jobs: Amphotericin B as antifungal and immunomodulatory drug.
    Mesa-Arango AC; Scorzoni L; Zaragoza O
    Front Microbiol; 2012; 3():286. PubMed ID: 23024638
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistance in human pathogenic fungi.
    Iwata K
    Eur J Epidemiol; 1992 May; 8(3):407-21. PubMed ID: 1397205
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The polyene macrolide antibiotics.
    Kerridge D
    Postgrad Med J; 1979 Sep; 55(647):653-6. PubMed ID: 392481
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effect of aeration and metabolic inhibitors on resistance to amphotericin in starved cultures of Candida albicans.
    Gale EF; Johnson AM; Kerridge D
    J Gen Microbiol; 1977 Mar; 99(1):77-84. PubMed ID: 325178
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Phenotypic resistance to amphotericin B in Candida albicans: relationship to glucan metabolism.
    Notario V; Gale EF; Kerridge D; Wayman F
    J Gen Microbiol; 1982 Apr; 128(4):761-77. PubMed ID: 6126520
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Factors affecting the changes in amphotericin sensitivity of Candida albicans during growth.
    Gale EF; Johnson AM; Kerridge D; Koh TY
    J Gen Microbiol; 1975 Mar; 87(1):20-36. PubMed ID: 1094096
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Reduction of amphotericin resistance in stationary phase cultures of Candida albicans by treatment with enzymes.
    Gale EF; Ingram J; Kerridge D; Notario V; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):383-91. PubMed ID: 6999116
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotypic resistance to miconazole and amphotericin B in Candida albicans.
    Gale EF; Johnson AM; Kerridge D; Wayman F
    J Gen Microbiol; 1980 Apr; 117(2):535-8. PubMed ID: 6999120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.